Intimal vascular lesions associated with female reproductive steroids.
D000293:Adolescent; D000328:Adult; D001158:Arteries / Q000473:pathology*; D001161:Arteriosclerosis / Q000473:pathology; D002318:Cardiovascular Diseases / Q000473:pathology; D002584:Cervix Uteri / Q000098:blood supply; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003331:Coronary Vessels / Q000473:pathology; D005260:Female; D006503:Hepatic Veins / Q000473:pathology; D006801:Humans; D007264:Inguinal Canal / Q000098:blood supply; D007889:Leiomyoma / Q000473:pathology; D008638:Mesenteric Arteries / Q000473:pathology; D008642:Mesenteric Veins / Q000473:pathology; D049590:Postpartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000473:pathology; D011372:Progestins / Q000009:adverse effects; D011644:Puerperal Disorders / Q000473:pathology; D011651:Pulmonary Artery / Q000473:pathology; D012077:Renal Artery / Q000473:pathology; D013997:Time Factors; D014594:Uterine Neoplasms / Q000473:pathology; D014652:Vascular Diseases / Q000139:chemically induced / Q000209:etiology*; D014680:Veins / Q000473:pathology*
D003276:Contraceptives, Oral; D011372:Progestins